These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35505736)

  • 21. [TAFRO syndrome showing cholangitis on liver biopsy].
    Nagai Y; Ando S; Honda N; Noguchi H; Maemori M; Hayashi T; Sakai H
    Rinsho Ketsueki; 2016; 57(12):2490-2495. PubMed ID: 28090015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment-resistant idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, renal dysfunction, and organomegaly managed with Janus kinase inhibitors: A case report.
    Kakutani T; Nunokawa T; Chinen N; Tamai Y
    Medicine (Baltimore); 2022 Dec; 101(48):e32200. PubMed ID: 36482523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with
    Hibi A; Mizuguchi K; Yoneyama A; Kasugai T; Kamiya K; Kamiya K; Ito C; Kominato S; Miura T; Koyama K
    Ren Replace Ther; 2018; 4(1):16. PubMed ID: 34171004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
    Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
    CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Mizutani KI; Kumagai M; Shioya A; Guo X; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Kida M; Yamada S
    Pathol Res Pract; 2019 Mar; 215(3):410-413. PubMed ID: 30642741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TAFRO Syndrome: A Disease Requiring Immediate Medical Attention.
    Masaki Y; Ueda Y; Yanagisawa H; Arita K; Sakai T; Yamada K; Mizuta S; Fukushima T; Takai K; Aoki S; Kawabata H
    Intern Med; 2023 Jan; 62(1):27-32. PubMed ID: 35598998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
    Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
    Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal histology in a patient with TAFRO syndrome: a case report.
    Mizuno H; Sekine A; Oguro M; Oshima Y; Kawada M; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Hoshino J; Sawa N; Fujii T; Takaichi K; Ohashi K; Ubara Y
    Hum Pathol; 2018 Dec; 82():258-263. PubMed ID: 29626596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
    Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr Virus-Positive Cutaneous and Systemic Plasmacytosis with TAFRO Syndrome-like Symptoms Successfully Treated with Rituximab.
    Kakiuchi S; Akiyama H; Harima I; Takagi I; Rikitake J; Kozuki Y; Inaba M; Fujiwara H; Kurose N; Yamada S; Masaki Y
    Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.
    Masaki Y; Kawabata H; Takai K; Kojima M; Tsukamoto N; Ishigaki Y; Kurose N; Ide M; Murakami J; Nara K; Yamamoto H; Ozawa Y; Takahashi H; Miura K; Miyauchi T; Yoshida S; Momoi A; Awano N; Ikushima S; Ohta Y; Furuta N; Fujimoto S; Kawanami H; Sakai T; Kawanami T; Fujita Y; Fukushima T; Nakamura S; Kinoshita T; Aoki S
    Int J Hematol; 2016 Jun; 103(6):686-92. PubMed ID: 27084250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TAFRO syndrome: A case report and review of the literature.
    Hou T; Dhillon J; Xiao W; Jaffe ES; Sands AM; Neppalli V; Deeb G; Zhang N
    Hum Pathol (N Y); 2017 Nov; 10():1-4. PubMed ID: 31608209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapy.
    Sakashita K; Murata K; Inagaki Y; Oota S; Takamori M
    Respirol Case Rep; 2016 Sep; 4(5):e00173. PubMed ID: 27516889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe coronavirus disease 2019 in a patient with TAFRO syndrome: A case report.
    Oshima K; Kanamori H; Takei K; Baba H; Tokuda K
    Clin Infect Pract; 2022 Nov; 16():100158. PubMed ID: 35919675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 Therapy.
    Williams C; Phillips A; Aggarwal V; Slonim LB; Fajgenbaum DC; Karmali R
    Case Rep Oncol; 2021; 14(3):1359-1365. PubMed ID: 34720942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
    Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
    BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tafro syndrome: Critical review for clinicians and pathologists.
    Paydas S
    Crit Rev Oncol Hematol; 2018 Aug; 128():88-95. PubMed ID: 29958635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CT findings in 11 patients with TAFRO syndrome: a variant of multicentric Castleman's disease.
    Kiguchi T; Sato C; Takai K; Nakai Y; Kaneko Y; Matsuki M
    Clin Radiol; 2017 Oct; 72(10):905.e1-905.e5. PubMed ID: 28629605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report.
    Noda-Narita S; Sumida K; Sekine A; Hoshino J; Mise K; Suwabe T; Hayami N; Yamanouchi M; Ueno T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K; Ohashi K; Fujii T; Ubara Y
    CEN Case Rep; 2018 May; 7(1):162-168. PubMed ID: 29468524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab.
    Suzuki K; Matsumoto T; Iwashita Y; Ishikura K; Fujioka M; Wada H; Katayama N; Imai H
    Int J Hematol; 2019 Jun; 109(6):737-743. PubMed ID: 30680669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.